user

Arcutis, Inc. Announces Positive Top Line Results for Phase 2b Clinical Trial Evaluating ARQ-151 as a Potential Topical Treatment for Plaque Psoriasis

Both tested doses of ARQ-151 demonstrated statistically significant superiority over vehicle Favorable safety and tolerability in this patient population ARQ-151...

Announces Name Change to EGF Health Holdings Corp., Pending Appointment of CEO and Director, and Effective Date for Plan of Arrangement with Theramed Health Corporation

VANCOUVER, BC / ACCESSWIRE / July 17, 2019 / EGF Health Holdings Corp. (formerly, Automated Techno Medical Corp.) (the “Company”)...

error: Content is protected !!